Related references
Note: Only part of the references are listed.Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
Dominic Mosha et al.
MALARIA JOURNAL (2014)
Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment
Denitsa Radeva-Petrova et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients
Robert L. Clark
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2012)
Profile: The KEMRI/CDC Health and Demographic Surveillance System-Western Kenya
Frank O. Odhiambo et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study
R. McGready et al.
LANCET INFECTIOUS DISEASES (2012)
Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda
Stephen Rulisa et al.
MALARIA JOURNAL (2012)
Influence of the Timing of Malaria Infection during Pregnancy on Birth Weight and on Maternal Anemia in Benin
Bich-Tram Huynh et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Patterns of anti-malarial drug treatment among pregnant women in Uganda
Laura R. Sangare et al.
MALARIA JOURNAL (2011)
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Jane Achan et al.
MALARIA JOURNAL (2011)
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority
Paul N. Newton et al.
MALARIA JOURNAL (2011)
Evaluation of the optimal recall period for disease symptoms in home-based morbidity surveillance in rural and urban Kenya
Daniel R. Feikin et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Health-seeking patterns among participants of population-based morbidity surveillance in rural western Kenya: implications for calculating disease rates
Godfrey Bigogo et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial
Patrice Piola et al.
LANCET INFECTIOUS DISEASES (2010)
Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia
Christine Manyando et al.
MALARIA JOURNAL (2010)
Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women
I. Adam et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2009)
Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester
Robert L. Clark
REPRODUCTIVE TOXICOLOGY (2009)
Sensitive periods for developmental toxicity of orally administered artesunate in the rat
Tacey E. K. White et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Pregnancy Exposure Registries for Assessing Antimalarial Drug Safety in Pregnancy in Malaria-Endemic Countries
Stephanie Dellicour et al.
PLOS MEDICINE (2008)
The safety of artemisinins during pregnancy: a pressing question
Stephanie Dellicour et al.
MALARIA JOURNAL (2007)
Measuring inequality with asset indicators
DJ McKenzie
JOURNAL OF POPULATION ECONOMICS (2005)
Recall bias in a case-control surveillance system on the use of medicine during pregnancy
M Rockenbauer et al.
EPIDEMIOLOGY (2001)
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy
JL Deen et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)